glp 1 renal benefits GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Glucagon-like Peptide Receptor Agonists and

They compared 175 health outcomes between veterans who took GLP-1RA drugs to treat their diabetes and those who took more traditional medications sold under brand names such as Jardiance, Glipizide and Januvia

The observed rate of thyroid cancer in patients prescribed liraglutide is similar to that of patients prescribed insulin

The goal is to keep choosing protein in forms you can tolerate, even if the portion is modest

Subjects with obesity treated with semaglutide for 12 weeks showed an average 24% reduction in energy intake over 3 meals/snacks and, similar to liraglutide, no effect on energy expenditure despite a decrease in resting metabolic rate (RMR)

This has solidified the therapeutic and commercial importance of GLP 1 analogues in obesity management, transforming them from niche products into cornerstone therapies for a wide spectrum of cardiometabolic conditions